Searchable abstracts of presentations at key conferences in endocrinology

ea0075d07 | Diabetes | EYES2021

Red blood cell membrane fluidity in type 2 diabetes mellitus

Emanuele Rizzo Gaetano , Laura Leo Maria , Salvatore Raia , Linda Tartaglione , Marco De Spirito , Giuseppe Maulucci , Alfredo Pontecorvi , Dario Pitocco

Background: Cell membrane fluidity of erythrocytes in patients with type 2 diabetes can be influenced by glycosylation processes, changes in lipid homeostasis and oxidative stress.Objectives: We have measured red blood cell membrane fluidity looking for differences between healthy people and diabetic subjects and also between diabetic patients affected by macroangiopathy (vascular diabetic foot) and not.Methods: We have enrolled 32...

ea0081p309 | Calcium and Bone | ECE2022

Testosterone supplementation and bone parameters, a systematic review and meta-analysis study

Vena Walter , Corona Giovanni , Pizzocaro Alessandro , Giagulli Vito , Francomano Davide , Rastrelli Giulia , Aversa Antonio , Marcello Isidori Andrea , Pivonello Rosario , Vignozzi Linda , Mannucci Edoardo , Maggi Mario , Ferlin Alberto

Background: Testosterone (T) is essential for bone health during all ages, helping to achieve a proper peak bone mass and, later, to maintain bone density and strength. Guidelines on management of male osteoporosis recommend testosterone replacement in young-adult hypogonadal to prevent bone loss and anti-resorbitive drugs in case of high fracture risk, but the role of T replacement therapy (TRT) alone in subjects with late onset hypogonadism is still the object of an intense ...

ea0063oc14.1 | Sex Hormones | ECE2019

Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial

Rastrelli Giulia , Cipriani Sarah , Lotti Francesco , Cellai Ilaria , Comeglio Paolo , Boddi Valentina , Della Camera Pierandrea , Gacci Mauro , Serni Sergio , Maggi Mario , Vignozzi Linda

Objectives: BPH is characterised by prostate inflammation, which frequently occurs in men with metabolic syndrome (MetS). MetS is often associated with low testosterone (T). Recent evidence shows that low, rather than high, T is associated with BPH/lower urinary tract symptoms (LUTS). To evaluate if T replacement therapy (TRT) for 6 months in BPH men with MetS and low T, is able to improve LUTS and prostate inflammation.Methods: 120 men in waiting list f...

ea0063p598 | Diabetes, Obesity and Metabolism 2 | ECE2019

Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit

Morelli Annamaria , Filippi Sandra , Comeglio Paolo , Sarchielli Erica , Cellai Ilaria , Danza Giovanna , Rastrelli Giulia , Corno Chiara , Zizza Michela , Guarnieri Giulia , Vignozzi Linda , Maggi Mario

Metabolic syndrome (MetS) clusters cardiovascular and metabolic risk factors, along with hypogonadism (HG) and erectile dysfunction (ED). Lifestyle modifications, including physical exercise (PhyEx), are well-known treatments for this condition. We previously established a non-genomic, high-fat diet (HFD)-induced rabbit model of MetS that recapitulates the human phenotype, including HG and ED. We now report studies on the effect of PhyEx on hypothalamus-pituitary-testis (HPT) ...

ea0063p604 | Diabetes, Obesity and Metabolism 2 | ECE2019

The effects of testosterone treatment on fat tissue dysfunction and nonalcoholic fatty liver disease in obese men undergoing bariatric surgery

Maseroli Elisa , Corno Chiara , Comeglio Paolo , Cellai Ilaria , Filippi Sandra , Mello Tommaso , Galli Andrea , Facchiano Enrico , Beltrame Benedetta , Lucchese Marcello , Rastrelli Giulia , Maggi Mario , Vignozzi Linda

Objective: Substitution treatment of hypogonadism in clinical and experimental models has shown beneficial effects on insulin sensitivity and accumulation of visceral and liver fat. Aim of the study was to analyze the effects of testosterone replacement therapy on benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS) clinical parameters, adipose tissue dysfunction and nonalcoholic fatty liver disease (NAFLD) in obese patients candidates for bariatric surgery.</p...

ea0063p652 | Interdisciplinary Endocrinology 1 | ECE2019

Restoring the sleep disruption by blue light emitting screen use in adolescents: a randomized controlled trial

Meijden Wisse P van der , Stenvers Dirk Jan , Kerkhof Linda van , Nierop Lotte van , Steeg Harry van , Bisschop Peter H , Someren Eus J van , Kalsbeek Andries

Introduction: Adolescents spend much time using blue-light emitting screen devices such as smartphones, tablets and computers. Blue light affects the central circadian clock in the suprachiasmatic nucleus (SCN) as well as melatonin secretion by the pineal gland. Screen use in adolescents strongly associates with reduced sleep quality and sleep duration. However, there is a lack of intervention studies that reduce blue light exposure due to screen use in adolescents.<p clas...

ea0063p808 | Thyroid 2 | ECE2019

Clinical presentation of hypothyroidism caused by TSH-receptor antibody

Jannin Arnaud , Peltier Lucas , D'Herbomez Michele , Defrance Frederique , Marcelli Sophie , Ben Hamou Adrien , Humbert Linda , Wemeau Jean-Louis , Vantyghem Marie-christine , Espiard Stephanie

Introduction: Anti-thyrotropin receptor antibodies (TSHR-Abs) stimulating the thyroid (TSAb) are responsible for GravesÂ’ disease. In some patients, the TSHR-Abs can block thyrotropin action (TBAb) and cause hypothyroidism, the switch between stimulating and blocking activity in GravesÂ’ disease being well. This reports aims to describe clinical presentation of patients affected directly by hypothyroidism.Material and methods: Retrospective clini...

ea0063p1123 | Reproductive Endocrinology 2 | ECE2019

Study of the anti-inflammatory effects of dihydrotestosterone in human vaginal smooth muscle cells

Maseroli Elisa , Cellai Ilaria , Corno Chiara , Rastrelli Giulia , Filippi Sandra , Comeglio Paolo , Amoriello Roberta , Ballerini Clara , Sarchielli Erica , Morelli Annamaria , Maggi Mario , Vignozzi Linda

Inflammation is hypothesized to play an important role in several diseases associated to the female genital tract and dihydrotestosterone (DHT) has shown immunomodulatory protective effects in experimental models of chronic inflammation. In the present study we aimed to evaluate the potential anti-inflammatory effects of DHT in a model of smooth muscle cells (hSMCs) isolated from human vagina biopsies and their potential role as APCs (Antigen Presenting Cells), crucial for the...

ea0049ep370 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance

Maseroli Elisa , Fanni Egidia , Cipriani Sarah , Scavello Irene , Pampaloni Francesca , Battaglia Cesare , Fambrini Massimiliano , Mannucci Edoardo , Jannini Emmanuele A , Maggi Mario , Vignozzi Linda

The relation between sexual and cardiovascular health in women is not well defined. Clitoral colour Doppler ultrasound (CDU) with assessment of the pulsatility index (PI), reflecting resistance to blood flow, has been proposed as an objective measurement of sexual functioning. We aimed to investigate the associations between clitoral PI and cardiometabolic risk factors. Seventy-one adult heterosexual women attending our clinic for sexual dysfunction were consecutively recruite...

ea0041gp56 | Cardiovascular endocrinology | ECE2016

The dual FXR/TGR5 agonist INT-767 reduces visceral fat mass, promoting preadipocyte brown differentiation, mitochondrial function and insulin sensitivity in a rabbit model of high fat diet-induced metabolic syndrome

Vignozzi Linda , Cellai Ilaria , Filippi Sandra , Comeglio Paolo , Mello Tommaso , Bani Daniele , Guasti Daniele , Sarchielli Erica , Morelli Annamaria , Maneschi Elena , Vannelli Gabriella Barbara , Adorini Luciano , Maggi Mario

Expanding brown adipose tissue is a potential therapeutic strategy to counteract insulin resistance and metabolic syndrome (MetS). Farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5) activation enhances insulin sensitivity, suggesting the capacity of FXR/TGR5 agonists to promote brown differentiation in adipose tissue. Treatment with increasing doses of the dual FXR/TGR5 agonist INT-767 (3, 10, 30 mg/Kg bw, daily for 5 days a week, by oral gavage, for 12 ...